<SEC-DOCUMENT>0001104659-23-105297-index.html : 20230929
<SEC-HEADER>0001104659-23-105297.hdr.sgml : 20230929
<ACCEPTANCE-DATETIME>20230929160143
ACCESSION NUMBER:		0001104659-23-105297
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		30
FILED AS OF DATE:		20230929
DATE AS OF CHANGE:		20230929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adlai Nortye Ltd.
		CENTRAL INDEX KEY:			0001944552
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-273465
		FILM NUMBER:		231295353

	BUSINESS ADDRESS:	
		STREET 1:		685 U.S. HIGHWAY ONE, 2ND FLOOR
		CITY:			NORTH BRUNSWICK
		STATE:			NJ
		ZIP:			08902
		BUSINESS PHONE:		848-230-7430

	MAIL ADDRESS:	
		STREET 1:		685 U.S. HIGHWAY ONE, 2ND FLOOR
		CITY:			NORTH BRUNSWICK
		STATE:			NJ
		ZIP:			08902
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>tm2225088-43_424b4.htm
<DESCRIPTION>424B4
<TEXT>
Document 1 - file: tm2225088-43_424b4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_adlainortye-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: lg_adlainortye-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2225088d1-tbl_pipelin4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: tm2225088d1-tbl_pipelin4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>fc_ourcorporate-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: fc_ourcorporate-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2225088d1-pht_head4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: tm2225088d1-pht_head4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2225088d1-pht_action4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: tm2225088d1-pht_action4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2225088d1-tbl_summary4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: tm2225088d1-tbl_summary4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2225088d1-lc_activity4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: tm2225088d1-lc_activity4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2225088d1-lc_survival4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: tm2225088d1-lc_survival4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2225088d1-lc_data4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: tm2225088d1-lc_data4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2225088d1-pht_mechani4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: tm2225088d1-pht_mechani4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2225088d1-lc_summary4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: tm2225088d1-lc_summary4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2225088d1-lc_antitum4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 13 - file: tm2225088d1-lc_antitum4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2225088d1-pht_ration4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 14 - file: tm2225088d1-pht_ration4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2225088d1-lc_triple4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 15 - file: tm2225088d1-lc_triple4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tm2225088d1-lc_combinat4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 16 - file: tm2225088d1-lc_combinat4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tm2225088d1-pht_mechan4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 17 - file: tm2225088d1-pht_mechan4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tm2225088d1-lc_model4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 18 - file: tm2225088d1-lc_model4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tm2225088d1-lc_treat4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 19 - file: tm2225088d1-lc_treat4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tm2225088d1-lc_activate4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 20 - file: tm2225088d1-lc_activate4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tm2225088d1-lc_immunec4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 21 - file: tm2225088d1-lc_immunec4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tm2225088d1-pht_dendrit4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 22 - file: tm2225088d1-pht_dendrit4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tm2225088d1-lc_sensitve4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 23 - file: tm2225088d1-lc_sensitve4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tm2225088d1-lc_effects4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 24 - file: tm2225088d1-lc_effects4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>lc_antitumor-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 25 - file: lc_antitumor-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tm2225088d1-fc_platform4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 26 - file: tm2225088d1-fc_platform4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tm2225088d1-pht_tech4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 27 - file: tm2225088d1-pht_tech4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>txt_adlainorty-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 28 - file: txt_adlainorty-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>txt_shanghi-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 29 - file: txt_shanghi-bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>txt_hangzhou-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 30 - file: txt_hangzhou-bw.jpg

</DOCUMENT>
</SEC-DOCUMENT>